Net Revenues

Name: ANI Pharmaceuticals Net Revenues by Business Segments
Creator: OpenCapital
License: https://www.opencapital.sh/terms

ANI Pharmaceuticals·Business Segments·2 segments·Rolls up to Total Revenue

Breakdown

Segment	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Rare Disease and Brands	$94.08M	$117.16M	$129.13M	$143.57M	$128.24M
Generics and Other	$103.04M	$94.21M	$98.69M	$103.49M	$109.22M
Total	$197.12M	$211.37M	$227.81M	$247.06M	$237.46M

Generics and OtherView metric

Rare Disease and BrandsView metric